Tranzyme Pharma (Nasdaq: TZYM) has closed the previously announced underwritten registered direct offering of approximately 3.0 million shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE